D-2-hydroxyglutarate interferes with HIF-1α stability skewing T-cell metabolism towards oxidative phosphorylation and impairing Th17 polarization

An Integrated Genomic Analysis of Human Glioblastoma Multiforme

Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857 · see citing works

<i>IDH1</i> and <i>IDH2</i> Mutations in Gliomas

Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847 · see citing works

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154 · see citing works

Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases

Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.-H., Ito, S., Yang, C., Wang, P., Xiao, M.-T., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.014 · Cited by 2,875 · see citing works

Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation

Figueroa, M. E., Abdel-Wahab, O., Lu, C., Ward, P. S., Patel, J., Shih, A., Li, Y., Bhagwat, N., Vasanthakumar, A., Fernandez, H. F., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.015 · Cited by 2,766 · see citing works

HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption

Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267 · see citing works

Recurring mutations found by sequencing an acute myeloid leukemia genome

Mardis, E. R., Ding, L., Dooling, D. J., Larson, D. E., McLellan, M. D., Chen, K., Koboldt, D. C., Fulton, R. S., Delehaunty, K. D., McGrath, S. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903840 · Cited by 2,219 · see citing works

Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets

Michalek, R. D., Gerriets, V. A., Jacobs, S. R., Macintyre, A. N., MacIver, N. J., Mason, E. F., Sullivan, S. A., Nichols, A. G., & Rathmell, J. C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003613 · Cited by 2,091 · see citing works

LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells

Brand, A., Singer, K., Koehl, G. E., Kolitzus, M., Schoenhammer, G., Thiel, A., Matos, C., Bruss, C., Klobuch, S., Peter, K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.011 · Cited by 2,039 · see citing works

The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate

Ward, P. S., Patel, J., Wise, D. R., Abdel-Wahab, O., Bennett, B. D., Coller, H. A., Cross, J. R., Fantin, V. R., Hedvat, C. V., Perl, A. E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.020 · Cited by 2,020 · see citing works

HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells

Shi, L. Z., Wang, R., Huang, G., Vogel, P., Neale, G., Green, D. R., & Chi, H. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110278 · Cited by 1,803 · see citing works

Mitochondria are required for antigen-specific t cell activation through reactive oxygen species signaling

Sena, L. A., Li, S., Jairaman, A., Prakriya, M., Ezponda, T., Hildeman, D. A., Wang, C.-R., Schumacker, P. T., Licht, J. D., Perlman, H., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.10.020 · Cited by 1,338 · see citing works

Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments

Angelin, A., Gil‐de‐Gómez, L., Dahiya, S., Jiao, J., Guo, L., Levine, M. H., Wang, Z., Quinn, W. J., Kopinski, P. K., Wang, L., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.018 · Cited by 1,263 · see citing works

DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival

Peterson, T. R., Laplante, M., Thoreen, C. C., Sancak, Y., Kang, S. A., Kuehl, W. M., Gray, N. S., & Sabatini, D. M. (2009) · Cell · doi:10.1016/j.cell.2009.03.046 · Cited by 1,202 · see citing works

T cell metabolism drives immunity

Buck, M. D., O’Sullivan, D., & Pearce, E. L. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20151159 · Cited by 1,190 · see citing works

Glucose Metabolism Regulates T Cell Activation, Differentiation, and Functions

Palmer, C. S., Ostrowski, M., Balderson, B., Christian, N., & Crowe, S. M. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00001 · Cited by 992 · see citing works

2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas

Choi, C., Ganji, S. K., DeBerardinis, R. J., Hatanpaa, K. J., Rakheja, D., Kovacs, Z., Yang, X.-L., Mashimo, T., Raisanen, J. M., Marin-Valencia, I., et al. (2012) · Nature Medicine · doi:10.1038/nm.2682 · Cited by 839 · see citing works

The who's who of <scp>T</scp> ‐cell differentiation: Human memory <scp>T</scp> ‐cell subsets

Mahnke, Y. D., Brodie, T. M., Sallusto, F., Roederer, M., & Lugli, E. (2013) · European Journal of Immunology · doi:10.1002/eji.201343751 · Cited by 817 · see citing works

Memory CD8+ T Cells Use Cell-Intrinsic Lipolysis to Support the Metabolic Programming Necessary for Development

O’Sullivan, D., van der Windt, G. J. W., Huang, S. C.-C., Curtis, J. D., Chang, C.-H., Buck, M. D., Qiu, J., Smith, A. M., Lam, W. Y., DiPlato, L. M., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.005 · Cited by 790 · see citing works

Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations

Gross, S., Cairns, R. A., Minden, M. D., Driggers, E. M., Bittinger, M. A., Jang, H. G., Sasaki, M., Jin, S., Schenkein, D. P., Su, S. M., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092506 · Cited by 736 · see citing works

Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation

Koivunen, P., Lee, S., Duncan, C. G., Lopez, G., Lu, G., Ramkissoon, S., Losman, J. A., Joensuu, P., Bergmann, U., Gross, S., et al. (2012) · Nature · doi:10.1038/nature10898 · Cited by 727 · see citing works

( <i>R</i> )-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible

Losman, J.-A., Looper, R. E., Koivunen, P., Lee, S., Schneider, R. K., McMahon, C., Cowley, G. S., Root, D. E., Ebert, B. L., & Kaelin, W. G. (2013) · Science · doi:10.1126/science.1231677 · Cited by 703 · see citing works

The Mammalian Target of Rapamycin (mTOR) Pathway Regulates Mitochondrial Oxygen Consumption and Oxidative Capacity

Schieke, S. M., Phillips, D., McCoy, J. P., Aponte, A. M., Shen, R.-F., Balaban, R. S., & Finkel, T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603536200 · Cited by 623 · see citing works

Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth

Sun, Q., Chen, X., Ma, J., Peng, H., Wang, F., Zha, X., Wang, Y., Jing, Y., Yang, H., Chen, R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014769108 · Cited by 586 · see citing works

Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia

Chan, S. M., Thomas, D., Corces, M. R., Xavy, S., Rastogi, S., Hong, W., Zhao, F., Medeiros, B. C., Tyvoll, D. A., & Majeti, R. (2015) · Nature Medicine · doi:10.1038/nm.3788 · Cited by 580 · see citing works

Hypoxic Regulation of Lactate Dehydrogenase A

Firth, J. D., Ebert, B. L., & Ratcliffe, P. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.36.21021 · Cited by 576 · see citing works

2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity

Sulkowski, P. L., Corso, C. D., Robinson, N. D., Scanlon, S. E., Purshouse, K. R., Bai, H., Liu, Y., Sundaram, R. K., Hegan, D. C., Fons, N. R., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal2463 · Cited by 556 · see citing works

Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy

Kishton, R. J., Sukumar, M., & Restifo, N. P. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.016 · Cited by 548 · see citing works

Hypoxia-inducible Factor 1α Is Regulated by the Mammalian Target of Rapamycin (mTOR) via an mTOR Signaling Motif

Land, S. C., & Tee, A. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611782200 · Cited by 507 · see citing works

IDH1andIDH2Mutations in Tumorigenesis: Mechanistic Insights and Clinical Perspectives

Yang, H., Ye, D., Guan, K., & Xiong, Y. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1773 · Cited by 459 · see citing works

S-2-hydroxyglutarate regulates CD8(+) T-lymphocyte fate

Tyrakis, P. A., Palazon, A., Macias, D., Lee, K. L., Phan, A. T., Veliça, P., You, J., Chia, G. S., Sim, J., Doedens, A., et al. (2016) · Nature · doi:10.1038/nature20165 · Cited by 433 · see citing works

MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis

Terunuma, A., Putluri, N., Mishra, P., Mathé, E. A., Dorsey, T. H., Yi, M., Wallace, T. A., Issaq, H. J., Zhou, M., Killian, J. K., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71180 · Cited by 428 · see citing works

<scp>mTOR</scp> , metabolism, and the regulation of T‐cell differentiation and function

Waickman, A. T., & Powell, J. D. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01152.x · Cited by 420 · see citing works

Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas

Kohanbash, G., Carrera, D. A., Shrivastav, S., Ahn, B. J., Jahan, N., Mazor, T., Chheda, Z. S., Downey, K., Watchmaker, P. B., Beppler, C., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90644 · Cited by 413 · see citing works

Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism

Xu, T., Stewart, K. M., Wang, X., Liu, K., Xie, M., Ryu, J. K., Li, K., Ma, T., Wang, H., Ni, L., et al. (2017) · Nature · doi:10.1038/nature23475 · Cited by 395 · see citing works

Emerging concepts of T cell metabolism as a target of immunotherapy

Chang, C., & Pearce, E. L. (2016) · Nature Immunology · doi:10.1038/ni.3415 · Cited by 337 · see citing works

Correlation of immune phenotype with IDH mutation in diffuse glioma

Berghoff, A. S., Kiesel, B., Widhalm, G., Wilhelm, D., Rajky, O., Kurscheid, S., Kresl, P., Wöehrer, A., Marosi, C., Hegi, M. E., et al. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox054 · Cited by 258 · see citing works

Mitochondrial Reactive Oxygen Species Control T Cell Activation by Regulating IL-2 and IL-4 Expression: Mechanism of Ciprofloxacin-Mediated Immunosuppression

Kamiński, M. M., Sauer, S. W., Klemke, C., Süss, D., Okun, J. G., Krammer, P. H., & Gülow, K. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901662 · Cited by 253 · see citing works

NADP+-IDH Mutations Promote Hypersuccinylation that Impairs Mitochondria Respiration and Induces Apoptosis Resistance

Li, F., He, X., Ye, D., Lin, Y., Yu, H., Yao, C., Huang, L., Zhang, J., Wang, F., Xu, S., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.017 · Cited by 244 · see citing works

A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression

Buller, C. L., Loberg, R. D., Fan, M., Zhu, Q., Park, J. L., Vesely, E. D., Inoki, K., Guan, K., & Brosius, F. C. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00554.2007 · Cited by 238 · see citing works

Precarious Balance: Th17 Cells in Host Defense

Peck, A., & Mellins, E. (2009) · Infection and Immunity · doi:10.1128/iai.00929-09 · Cited by 236 · see citing works

2-Hydroxyglutarate Inhibits ATP Synthase and mTOR Signaling

Fu, X., Chin, R., Vergnes, L., Hwang, H., Deng, G., Xing, Y., Pai, M. Y., Li, S., Ta, L. H., Fazlollahi, F., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.06.009 · Cited by 230 · see citing works

Mitochondrial metabolism contributes to oxidative stress and reveals therapeutic targets in chronic lymphocytic leukemia

Jitschin, R., Hofmann, A. D., Bruns, H., Gießl, A., Bricks, J., Berger, J., Saul, D., Eckart, M. J., Mackensen, A., & Mougiakakos, D. (2014) · Blood · doi:10.1182/blood-2013-10-532200 · Cited by 201 · see citing works

Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia

Dinardo, C. D., PROPERT, K. J., Loren, A. W., Paietta, E. M., Sun, Z., Levine, R. L., Straley, K. S., Yen, K. E., Patel, J. P., Agresta, S. V., et al. (2013) · Blood · doi:10.1182/blood-2013-03-493197 · Cited by 197 · see citing works

Naturally occurring regulatory T cells show reduced sensitivity toward oxidative stress–induced cell death

Mougiakakos, D., Johansson, C. C., & Kiessling, R. W. (2008) · Blood · doi:10.1182/blood-2008-09-181040 · Cited by 195 · see citing works

Redox regulation of the hypoxia-inducible factor

Pouysségur, J., & Mechta-Grigoriou, F. (2006) · Biological Chemistry · doi:10.1515/bc.2006.167 · Cited by 186 · see citing works

The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway

Carbonneau, M., M. Gagné, L., Lalonde, M.-E., Germain, M.-A., Motorina, A., Guiot, M.-C., Secco, B., Vincent, E. E., Tumber, A., Hulea, L., et al. (2016) · Nature Communications · doi:10.1038/ncomms12700 · Cited by 180 · see citing works

Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress

Mougiakakos, D., Johansson, C. C., Jitschin, R., Böttcher, M., & Kiessling, R. W. (2010) · Blood · doi:10.1182/blood-2010-09-307041 · Cited by 170 · see citing works

Identification of a dehydrogenase acting on D -2-hydroxyglutarate

Achouri, Y., NOËL, G., Vertommen, D., Rider, M. H., Veiga‐da‐Cunha, M., & SCHAFTINGEN, E. V. (2004) · Biochemical Journal · doi:10.1042/bj20031933 · Cited by 129 · see citing works

O-GlcNAcylation and Metabolic Reprograming in Cancer

Åowiak, P. J., Forma, E., Bryś, M., & Krześlak, A. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00145 · Cited by 119 · see citing works

2-Hydroxyglutarate Production, but Not Dominant Negative Function, Is Conferred by Glioma-Derived NADP+-Dependent Isocitrate Dehydrogenase Mutations

Jin, G., Reitman, Z. J., Spasojevic, I., Batinic-Haberle, I., Yang, J., Schmidt-Kittler, O., Bigner, D. D., & Yan, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016812 · Cited by 112 · see citing works

D‐2‐hydroxyglutaric acid induces oxidative stress in cerebral cortex of young rats

Latini, A., Scussiato, K., Rosa, R. B., Llesuy, S., Belló‐Klein, A., Dutra‐Filho, C. S., & Wajner, M. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02639.x · Cited by 112 · see citing works

Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenase

Curti, A., Aluigi, M., Pandolfi, S., Ferri, E., Isidori, A., Salvestrini, V., Durelli, I., Horenstein, A. L., Fiore, F., Massaia, M., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404485 · Cited by 109 · see citing works

Posttranslational, Reversible O-Glycosylation Is Stimulated by High Glucose and Mediates Plasminogen Activator Inhibitor-1 Gene Expression and Sp1 Transcriptional Activity in Glomerular Mesangial Cells

Goldberg, H. J., Whiteside, C. I., Hart, G. W., & Fantus, I. G. (2005) · Endocrinology · doi:10.1210/en.2005-0523 · Cited by 107 · see citing works

Monocytic AML cells inactivate antileukemic lymphocytes: role of NADPH oxidase/gp91phox expression and the PARP-1/PAR pathway of apoptosis

Aurelius, J., Thorén, F. B., Akhiani, A. A., Brune, M. L., Palmqvist, L., Hansson, M., Hellstrand, K., & Martner, A. (2012) · Blood · doi:10.1182/blood-2011-11-391722 · Cited by 106 · see citing works

Th17 cells and interleukin‐17 increase with poor prognosis in patients with acute myeloid leukemia

Han, Y., Ye, A., Bi, L., Wu, J., Kang, Y., & Zhang, S. (2014) · Cancer Science · doi:10.1111/cas.12459 · Cited by 105 · see citing works

Increased frequencies of T helper type 17 cells in the peripheral blood of patients with acute myeloid leukaemia

Wu, C., Wang, S., Wang, F., Chen, Q., Peng, S., Zhang, Y., Qian, J., Jin, J., & Xu, H. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.04011.x · Cited by 99 · see citing works

Cancer-associated Isocitrate Dehydrogenase 1 (IDH1) R132H Mutation and d-2-Hydroxyglutarate Stimulate Glutamine Metabolism under Hypoxia

Reitman, Z. J., Duncan, C. G., Poteet, E. C., Winters, A., Yan, L., Gooden, D. M., Spasojević, I., Boros, L. G., Yang, S.-H., & Yan, H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.575183 · Cited by 90 · see citing works

Infections in acute leukemia: an analysis of 240 febrile episodes

Jagarlamudi, R., Kumar, L., Kochupillai, V., Kapil, A., Banerjee, U., & Thulkar, S. P. (2000) · Medical Oncology · doi:10.1007/bf02796205 · Cited by 70 · see citing works

An IDH1 mutation inhibits growth of glioma cells via GSH depletion and ROS generation

Shi, J., Zuo, H., Ni, L., Xia, L., Zhao, L., Gong, M., Nie, D., Gong, P., Cui, D., Shi, W., et al. (2013) · Neurological Sciences · doi:10.1007/s10072-013-1607-2 · Cited by 67 · see citing works

Enzymatic assay for quantitative analysis of (d)-2-hydroxyglutarate

Balß, J., Pusch, S., Beck, A.-C., Herold‐Mende, C. C., Krämer, A., Thiede, C., Buckel, W., Langhans, C., Okun, J. G., & von Deimling, A. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1060-y · Cited by 63 · see citing works

Mesenchymal Stromal Cells Disrupt mTOR-Signaling and Aerobic Glycolysis During T-Cell Activation

Böttcher, M., Hofmann, A. D., Bruns, H., Haibach, M., Loschinski, R., Saul, D., Mackensen, A., Blanc, K. L., Jitschin, R., & Mougiakakos, D. (2015) · Stem Cells · doi:10.1002/stem.2234 · Cited by 56 · see citing works

D-2-hydroxyglutarate is essential for maintaining oncogenic property of mutant IDH-containing cancer cells but dispensable for cell growth

Ma, S., Jiang, B., Deng, W., Gu, Z.-K., Wu, F.-Z., Li, T., Xia, Y., Yang, H., Ye, D., Xiong, Y., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3330 · Cited by 55 · see citing works

The effect of HIF-1α on glucose metabolism, growth and apoptosis of pancreatic cancerous cells.

He, G., Jiang, Y., Zhang, B., & Wu, G. (2014) · PubMed · doi:10.6133/apjcn.2014.23.1.14 · Cited by 54 · see citing works

The Profile of T Helper Subsets in Bone Marrow Microenvironment Is Distinct for Different Stages of Acute Myeloid Leukemia Patients and Chemotherapy Partly Ameliorates These Variations

Tian, T., Yu, S., Liu, L., Xue, F., Yuan, C., Wang, M., Ji, C., & Ma, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131761 · Cited by 48 · see citing works

Enantiomer-specific and paracrine leukemogenicity of mutant IDH metabolite 2-hydroxyglutarate

Chaturvedi, A., Cruz, M. M. A., Jyotsana, N., Sharma, A., Goparaju, R., Schwarzer, A., Görlich, K., Schottmann, R., Struys, E. A., Jansen, E. E. W., et al. (2016) · Leukemia · doi:10.1038/leu.2016.71 · Cited by 48 · see citing works

Prognostic value of Th17 cells in acute leukemia

Abousamra, N. K., El-Din, M. S., & Helal, R. (2013) · Medical Oncology · doi:10.1007/s12032-013-0732-3 · Cited by 35 · see citing works

Pretreatment d-2-hydroxyglutarate serum levels negatively impact on outcome in IDH1-mutated acute myeloid leukemia

Balss, J., Thiede, C., Bochtler, T., Okun, J. G., Saadati, M., Benner, A., Pusch, S., Ehninger, G., Schaich, M. A., Ho, A. D., et al. (2015) · Leukemia · doi:10.1038/leu.2015.317 · Cited by 24 · see citing works

Aberrant T Helper 17 Cells and Related Cytokines in Bone Marrow Microenvironment of Patients with Acute Myeloid Leukemia

Tian, T., Yu, S., Wang, M., Yuan, C., Zhang, H., Ji, C., & Ma, D. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/915873 · Cited by 13 · see citing works

Glycolysis – a key player in the inflammatory response

Soto‐Heredero, G., Heras, M. M. G. D. L., Gabandé‐Rodríguez, E., Oller, J., & Mittelbrunn, M. (2020) · FEBS Journal · doi:10.1111/febs.15327 · Cited by 645 · see citing works

The functional roles of TCA cycle metabolites in cancer

Eniafe, J., & Jiang, S. (2021) · Oncogene · doi:10.1038/s41388-020-01639-8 · Cited by 274 · see citing works

The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts

Friščić, J., Böttcher, M., Reinwald, C., Bruns, H., Wirth, B., Popp, S.-J., Walker, K., Ackermann, J. A., Chen, X., Turner, J. D., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.03.003 · Cited by 252 · see citing works

2-Oxoglutarate-dependent dioxygenases in cancer

Losman, J.-A., Koivunen, P., & Kaelin, W. G. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-00303-3 · Cited by 225 · see citing works

Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity

Yan, Y., Huang, L., Liu, Y., Yi, M., Chu, Q., Jiao, D., & Wu, K. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01322-3 · Cited by 222 · see citing works

HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells

Lee, S.-H., Golinska, M., & Griffiths, J. R. (2021) · Cells · doi:10.3390/cells10092371 · Cited by 169 · see citing works

The Roles of 2-Hydroxyglutarate

Du, X., & Hu, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.651317 · Cited by 152 · see citing works

T Cell Metabolism in Infection

Wik, J. A., & Skålhegg, B. S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.840610 · Cited by 148 · see citing works

2-Hydroxyglutarate in Cancer Cells

Ježek, P. (2020) · Antioxidants &amp; Redox Signaling · doi:10.1089/ars.2019.7902 · Cited by 130 · see citing works

The immunological Warburg effect: Can a metabolic‐tumor‐stroma score (MeTS) guide cancer immunotherapy?

Siska, P. J., Singer, K., Evert, K., Renner, K., & Kreutz, M. P. (2020) · Immunological Reviews · doi:10.1111/imr.12846 · Cited by 123 · see citing works

Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy

Lian, X., Yang, K., Li, R., Li, M., Zuo, J., Zheng, B., Wang, W., Wang, P., & Zhou, S. (2022) · Molecular Cancer · doi:10.1186/s12943-021-01486-5 · Cited by 120 · see citing works

Dimethyl itaconate, an itaconate derivative, exhibits immunomodulatory effects on neuroinflammation in experimental autoimmune encephalomyelitis

Kuo, P., Weng, W., Scofield, B. A., Paraiso, H. C., Brown, D. A., Wang, P., Yu, I.-C. I., & Yen, J.-H. J. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01768-7 · Cited by 112 · see citing works

IDH-mutated gliomas promote epileptogenesis through d -2-hydroxyglutarate-dependent mTOR hyperactivation

Mortazavi, A., Fayed, I., Bachani, M., Dowdy, T., Jahanipour, J., Khan, A. U., Owotade, J., Walbridge, S., Inati, S. K., Steiner, J. P., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac003 · Cited by 92 · see citing works

The oncometabolite 2-hydroxyglutarate inhibits microglial activation via the AMPK/mTOR/NF-κB pathway

Han, C., Zheng, J., Sun, L., Yang, H., Cao, Z., Zhang, X., Zheng, L. T., & Zhen, X.-C. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0225-9 · Cited by 73 · see citing works

Metabolic regulation of TH17 cells

Shen, H., & Shi, L. Z. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.03.005 · Cited by 68 · see citing works

Effects of lactate on metabolism and differentiation of CD4+T cells

Zhang, Y., Xing, M.-L., Fang, H.-H., Li, W., Wu, L., & Chen, Z. (2023) · Molecular Immunology · doi:10.1016/j.molimm.2022.12.015 · Cited by 69 · see citing works

Targeting IDH-Mutant Glioma

Miller, J. J. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01238-3 · Cited by 69 · see citing works

Impact of epigenetic reprogramming on antitumor immune responses in glioma

McClellan, B. L., Haase, S., Núñez, F. J., Alghamri, M. S., Dabaja, A. A., Lowenstein, P. R., & Castro, M. G. (2023) · Journal of Clinical Investigation · doi:10.1172/jci163450 · Cited by 68 · see citing works

The effects of 2-hydroxyglutarate on the tumorigenesis of gliomas

Reiter–Brennan, C., Semmler, L., & Klein, A. (2018) · Współczesna Onkologia · doi:10.5114/wo.2018.82642 · Cited by 56 · see citing works

Signaling metabolite L-2-hydroxyglutarate activates the transcription factor HIF-1α in lipopolysaccharide-activated macrophages

Williams, N. C., Ryan, D. G., Costa, A. S. H., Mills, E. L., Jedrychowski, M. P., Cloonan, S. M., Frezza, C., & O'Neill, L. A. J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101501 · Cited by 56 · see citing works

Mitochondrial Genetic and Epigenetic Regulations in Cancer: Therapeutic Potential

Wagner, A., Kosnacova, H., Chovanec, M., & Jurkovičová, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147897 · Cited by 51 · see citing works

Targeting metabolic-epigenetic-immune axis in cancer: molecular mechanisms and therapeutic implications

Wang, X., Luo, X., Xiao, R., Liu, X., Zhou, F., Jiang, D., Bai, J., Cui, M., You, L., & Yupei, Z. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02334-4 · Cited by 57 · see citing works

IDH-mutant gliomas harbor fewer regulatory T cells in humans and mice

Richardson, L. G., Nieman, L. T., Stemmer-Rachamimov, A. O., Zheng, X. S., Stafford, K., Nagashima, H., Miller, J. J., Kiyokawa, J., Ting, D. T., Wakimoto, H., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1806662 · Cited by 50 · see citing works

Shaping of Dendritic Cell Function by the Metabolic Micro-Environment

Brombacher, E. C., & Everts, B. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00555 · Cited by 47 · see citing works

Human Double-Negative Regulatory T-Cells Induce a Metabolic and Functional Switch in Effector T-Cells by Suppressing mTOR Activity

Haug, T., Aigner, M., Peuser, M., Strobl, C. D., Hildner, K. M., Mougiakakos, D., Bruns, H., Mackensen, A., & Völkl, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00883 · Cited by 46 · see citing works

The Interplay Between the Genetic and Immune Landscapes of AML: Mechanisms and Implications for Risk Stratification and Therapy

Mendez, L., Posey, R. R., & Pandolfi, P. P. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01162 · Cited by 46 · see citing works

Systemic and local immunosuppression in glioblastoma and its prognostic significance

Stepanenko, A. A., Sosnovtseva, A. O., Valikhov, M. P., Chernysheva, A. A., Abramova, O. V., Ka, P., & Chekhonin, V. P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1326753 · Cited by 46 · see citing works

IDH Mutations in Glioma: Molecular, Cellular, Diagnostic, and Clinical Implications

Choate, K. A., Pratt, E. P. S., Jennings, M. J., Winn, R. J., & Mann, P. B. (2024) · Biology · doi:10.3390/biology13110885 · Cited by 43 · see citing works

Tumor-related molecular determinants of neurocognitive deficits in patients with diffuse glioma

van Kessel, E., Berendsen, S., Baumfalk, A. E., Venugopal, H., Krijnen, E. A., Spliet, W. G. M., Hecke, W. V., Giuliani, F., Seute, T., van Zandvoort, M. J. E., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac036 · Cited by 39 · see citing works

Immunometabolism of regulatory T cells in cancer

Saravia, J., & Chi, H. (2025) · Oncogene · doi:10.1038/s41388-025-03458-1 · Cited by 40 · see citing works

Oncometabolite Fingerprinting Using Fluorescent Single‐Walled Carbon Nanotubes

Amir, D., Hendler‐Neumark, A., Wulf, V., Ehrlich, R., & Bisker, G. (2021) · Advanced Materials Interfaces · doi:10.1002/admi.202101591 · Cited by 37 · see citing works

The promising therapeutic effects of metformin on metabolic reprogramming of cancer-associated fibroblasts in solid tumors

Mostafavi, S., Zalpoor, H., & Hassan, Z. M. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00356-2 · Cited by 37 · see citing works

Selective PRMT5 Inhibitors Suppress Human CD8+ T Cells by Upregulation of p53 and Impairment of the AKT Pathway Similar to the Tumor Metabolite MTA

Strobl, C. D., Schaffer, S., Haug, T., Völkl, S., Peter, K., Singer, K., Böttcher, M., Mougiakakos, D., Mackensen, A., & Aigner, M. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0189 · Cited by 35 · see citing works

Energy metabolism is co-determined by genetic variants in chronic lymphocytic leukemia and influences drug sensitivity

Lu, J., Böttcher, M., Walther, T., Mougiakakos, D., Zenz, T., & Huber, W. K. (2019) · Haematologica · doi:10.3324/haematol.2018.203067 · Cited by 31 · see citing works

Epigenetic Reprogramming for Targeting IDH-Mutant Malignant Gliomas

Park, J., & Turcan, Ş. (2019) · Cancers · doi:10.3390/cancers11101616 · Cited by 31 · see citing works

Harnessing oxidative stress for anti-glioma therapy

Ostrowski, R. P., & Pucko, E. B. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105281 · Cited by 30 · see citing works

2-Hydroxyglutarate in Acute Myeloid Leukemia: A Journey from Pathogenesis to Therapies

Raimondi, V., Ciotti, G., Gottardi, M., & Ciccarese, F. (2022) · Biomedicines · doi:10.3390/biomedicines10061359 · Cited by 31 · see citing works

Rationale design of novel substituted 1,3,5-triazine candidates as dual IDH1(R132H)/ IDH2(R140Q) inhibitors with high selectivity against acute myeloid leukemia: In vitro and in vivo preclinical investigations

Tawfik, H. O., Mousa, M. H. A., Zaky, M. Y., El‐Dessouki, A. M., Sharaky, M. M., Abdullah, O., El‐Hamamsy, M. H., & Al-Karmalawy, A. A. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107483 · Cited by 28 · see citing works

D-2-Hydroxyglutarate and L-2-Hydroxyglutarate Inhibit IL-12 Secretion by Human Monocyte-Derived Dendritic Cells

Ugele, I., Cárdenas-Conejo, Z. E., Hammon, K., Wehrstein, M., Bruß, C., Peter, K., Singer, K., Gottfried, E., Boesch, J., Oefner, P. J., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030742 · Cited by 27 · see citing works

Targeting the Metabolic Paradigms in Cancer and Diabetes

Bosso, M., Haddad, D., Madhoun, A. S. A., & Al‐Mulla, F. (2024) · Biomedicines · doi:10.3390/biomedicines12010211 · Cited by 26 · see citing works

Emerging targets for anticancer vaccination: IDH

Platten, M., Bunse, L., & Wick, W. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100214 · Cited by 26 · see citing works

Advances in Immune Microenvironment and Immunotherapy of Isocitrate Dehydrogenase Mutated Glioma

Yan, D., Li, W., Liu, Q., & Yang, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.914618 · Cited by 26 · see citing works

Oncometabolite 2-hydroxyglutarate regulates anti-tumor immunity

Cai, M., Zhao, J., Ding, Q., & Wei, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24454 · Cited by 26 · see citing works

Immunometabolism: A ‘Hot’ Switch for ‘Cold’ Pediatric Solid Tumors

Xiao, L., Yeung, H., Haber, M., Norris, M. D., & Somers, K. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.05.002 · Cited by 25 · see citing works

Targeting the metabolism and immune system in pancreatic ductal adenocarcinoma: Insights and future directions

Bandi, D. S. R., Sarvesh, S., Farran, B., Nagaraju, G. P., & El‐Rayes, B. F. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.06.006 · Cited by 25 · see citing works

Potent immunosuppressive effects of the oncometaboliteR-2-hydroxyglutarate

Galluzzi, L., & Kroemer, G. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1528815 · Cited by 25 · see citing works

Illuminating the cross-talk between tumor metabolism and immunity in IDH-mutated cancers

Leca, J., Fortin, J., & Mak, T. W. (2020) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2020.11.013 · Cited by 23 · see citing works

Cellular metabolism dictates T cell effector function in health and disease

Kolan, S. S., Li, G., Wik, J. A., Malachin, G., Guo, S., Kolan, P., & Skålhegg, B. S. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12956 · Cited by 24 · see citing works

GEM-IL: A highly responsive fluorescent lactate indicator

Bekdash, R., Quejada, J. R., Ueno, S., Kawano, F., Morikawa, K., Klein, A. D., Matsumoto, K., Lee, T. C., Nakanishi, K., Chalan, A., et al. (2021) · Cell Reports Methods · doi:10.1016/j.crmeth.2021.100092 · Cited by 24 · see citing works

Regulation of immune cell metabolism in health and disease: Special focus on T and B cell subsets

Chakraborty, S., Khamaru, P., & Bhattacharyya, A. (2022) · Cell Biology International · doi:10.1002/cbin.11867 · Cited by 24 · see citing works

Interaction and Collaboration of SP1, HIF-1, and MYC in Regulating the Expression of Cancer-Related Genes to Further Enhance Anticancer Drug Development

Kimura, K., Jackson, T. L. B., & Huang, R. C. C. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45110580 · Cited by 23 · see citing works

The Oncometabolite 5′-Deoxy-5′-Methylthioadenosine Blocks Multiple Signaling Pathways of NK Cell Activation

Jacobs, B., Schlögl, S., Strobl, C. D., Völkl, S., Stoll, A., Mougiakakos, D., Malmberg, K., Mackensen, A., & Aigner, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02128 · Cited by 23 · see citing works

Differential metabolic requirement governed by transcription factor c-Maf dictates innate γδT17 effector functionality in mice and humans

Chen, X., Cai, Y., Hu, X., Ding, C., He, L., Zhang, X., Chen, F., & Yan, J. (2022) · Science Advances · doi:10.1126/sciadv.abm9120 · Cited by 22 · see citing works

CLL-Derived Extracellular Vesicles Impair T-Cell Activation and Foster T-Cell Exhaustion via Multiple Immunological Checkpoints

Böttcher, M., Loschinski, R., Kahlfuß, S., Aigner, M., Gießl, A., Mackensen, A., Schlötzer-Schrehardt, U. M., Tüting, T., Bruns, H., & Mougiakakos, D. (2022) · Cells · doi:10.3390/cells11142176 · Cited by 22 · see citing works

The Roles of IDH1 in Tumor Metabolism and Immunity

Ni, Y., Shen, P., Wang, X. T., Liu, H., Luo, H., & Han, X. (2022) · Future Oncology · doi:10.2217/fon-2022-0583 · Cited by 23 · see citing works

Amino Acid and Glucose Fermentation Maintain ATP Content in Mouse and Human Malignant Glioma Cells

Lee, D. C., Ta, N. L., Mukherjee, P., Duraj, T., Domin, M. A., Greenwood, B. P., Karmacharya, S., Narain, N. R., Kiebish, M. A., Chinopoulos, C., et al. (2024) · ASN NEURO · doi:10.1080/17590914.2024.2422268 · Cited by 21 · see citing works

Perspectives of immunotherapy in isocitrate dehydrogenase-mutant gliomas

Friedrich, M., Bunse, L., Wick, W., & Platten, M. (2018) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000478 · Cited by 21 · see citing works

Metabolic regulation of innate and adaptive lymphocyte effector responses

Joseph, A. M., Monticelli, L. A., & Sonnenberg, G. F. (2018) · Immunological Reviews · doi:10.1111/imr.12703 · Cited by 21 · see citing works

An analysis of Treg/Th17 cells imbalance associated microRNA networks regulated by moxibustion therapy on Zusanli (ST36) and Shenshu (BL23) in mice with collagen induced arthritis.

Zhao, C., Li, X., Yang, Y., Li, Z., Li, M., Tan, Q., Liang, W. H., & Liu, Z. (2019) · PubMed Central · Cited by 21 · see citing works

Immunosuppressive microenvironment in acute myeloid leukemia: overview, therapeutic targets and corresponding strategies

Zha, C., Yang, X., Yang, J., Zhang, Y., & Huang, R. (2024) · Annals of Hematology · doi:10.1007/s00277-024-06117-9 · Cited by 22 · see citing works

New insights into the Immune TME of adult-type diffuse gliomas

Richard, Q., Laurenge, A., Mallat, M., Sanson, M., & Castro‐Vega, L. J. (2022) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001112 · Cited by 20 · see citing works

Hypoxic Transformation of Immune Cell Metabolism Within the Microenvironment of Oral Cancers

Chaudhary, A., Bag, S., Arora, N., Radhakrishnan, V. S., Mishra, D. K., & Mukherjee, G. (2020) · Frontiers in Oral Health · doi:10.3389/froh.2020.585710 · Cited by 19 · see citing works

Metabolic Rewiring in Radiation Oncology Toward Improving the Therapeutic Ratio

van Gisbergen, M. W., Zwilling, E., & Dubois, L. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.653621 · Cited by 20 · see citing works

The two enantiomers of 2-hydroxyglutarate differentially regulate cytotoxic T cell function

Foskolou, I. P., Cunha, P. P., Sánchez‐López, E., Minogue, E., Nicolet, B. P., Guislain, A., Jorgensen, C., Kostidis, S., Zandhuis, N. D., Barbieri, L., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113013 · Cited by 19 · see citing works

The connection between tricarboxylic acid cycle enzyme mutations and pseudohypoxic signaling in pheochromocytoma and paraganglioma

Wang, Y., Liu, B., Li, F., Zhang, Y., Gao, X., Wang, Y., & Zhou, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1274239 · Cited by 18 · see citing works

The Role and Applied Value of Mitochondria in Glioma‐Related Research

Chen, L., Zhang, H., Shang, C., & Hong, Y. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70121 · Cited by 18 · see citing works

The Induction of a Permissive Environment to Promote T Cell Immune Evasion in Acute Myeloid Leukemia: The Metabolic Perspective

Mougiakakos, D. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01166 · Cited by 18 · see citing works

MAIT cells numbers and frequencies in patients with acute myeloid leukemia at diagnosis: association with cytogenetic profile and gene mutations

Comont, T., Nicolau-Travers, M.-L., Bertoli, S., Récher, C., Vergez, F., & Treiner, E. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-03037-9 · Cited by 16 · see citing works

Checkpoint Inhibitors in Acute Myeloid Leukemia

Damiani, D., & Tiribelli, M. (2023) · Biomedicines · doi:10.3390/biomedicines11061724 · Cited by 16 · see citing works

Isocitrate Dehydrogenase Mutations in Cancer: Mechanisms of Transformation and Metabolic LiabilityPreprint

Gunn, K., & Losman, J.-A. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041537 · Cited by 16 · see citing works

Deciphering the multifaceted roles and clinical implications of 2-hydroxyglutarate in cancer

Hao, J., Huang, Z., Zhang, S., Song, K., Wang, J., Gao, C., Fang, Z., & Zhang, N. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107437 · Cited by 15 · see citing works

2-hydroxyglutarate rides the cancer-immunity cycle

Foskolou, I. P., Bunse, L., & den Bossche, J. V. (2023) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2023.102976 · Cited by 15 · see citing works

D-Mannose Suppresses γδ T Cells and Alleviates Murine Psoriasis

Li, M., Cheng, H., Tian, D., Yang, L., Du, X., Pan, Y., Zhang, D., & Mei, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.840755 · Cited by 15 · see citing works

A preventative role of nitrate for hypoxia-induced intestinal injury

Xu, Y., Sa, Y., Zhang, C., Wang, J., Shao, Q., Liu, J., Wang, S., & Zhou, J. W. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.01.030 · Cited by 14 · see citing works

Degradation of D-2-hydroxyglutarate in the presence of isocitrate dehydrogenase mutations

Berger, R. S., Ellmann, L., Reinders, J., Kreutz, M. P., Stempfl, T., Oefner, P. J., & Dettmer, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-43891-3 · Cited by 14 · see citing works

2-Hydroxyglutarate Metabolism Is Altered in an in vivo Model of LPS Induced Endotoxemia

Fitzpatrick, S. F., Lambden, S., Macías, D., Puthucheary, Z., Pietsch, S., Mendil, L., McPhail, M. J. W., & Johnson, R. S. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00147 · Cited by 14 · see citing works

D-2-hydroxyglutarate supports a tolerogenic phenotype with lowered major histocompatibility class II expression in non-malignant dendritic cells and acute myeloid leukemia cells

Hammon, K., Renner, K., Althammer, M., Voll, F., Babl, N., Decking, S.-M., Siska, P. J., Matos, C., Cárdenas-Conejo, Z. E., Mendes, K., et al. (2024) · Haematologica · doi:10.3324/haematol.2023.283597 · Cited by 13 · see citing works

Crosstalk of Epigenetic and Metabolic Signaling Underpinning Glioblastoma Pathogenesis

Markouli, M., Strepkos, D., Papavassiliou, K. A., Papavassiliou, A. G., & Piperi, C. (2022) · Cancers · doi:10.3390/cancers14112655 · Cited by 11 · see citing works

From Metabolism to Genetics and Vice Versa: The Rising Role of Oncometabolites in Cancer Development and Therapy

Gregorio, E. D., Miolo, G., Saorin, A., Steffan, A., & Corona, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115574 · Cited by 11 · see citing works

Isocitrate dehydrogenases 2-mediated dysfunctional metabolic reprogramming promotes intestinal cancer progression via regulating HIF-1A signaling pathway

Liu, S., Zhou, Y., Chen, Y., Qiao, Y., Bai, L., Zhang, S., Men, D., Zhang, H., Pan, F., Gao, Y., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112828 · Cited by 10 · see citing works

Tricarboxylic Acid Cycle Relationships with Non-Metabolic Processes: A Short Story with DNA Repair and Its Consequences on Cancer Therapy Resistance

Álvarez-González, E., & Sierra, L. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25169054 · Cited by 10 · see citing works

Identification of co-expressed gene networks promoting CD8+ T cell infiltration and having prognostic value in uveal melanoma

Zhang, C., Xiao, J., Fa, L., Jiang, F., Jiang, H., Zhou, L., & Xu, Z. (2023) · BMC Ophthalmology · doi:10.1186/s12886-023-03098-7 · Cited by 9 · see citing works

Rapamycin ameliorates immune-mediated aplastic anemia by inhibiting the proliferation and metabolism of T cells

Liu, S.-L., Zhou, Y., Tang, D.-B., Zhou, N., Zheng, W., Tang, Z.-H., Duan, C., & Chen, J. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.08.034 · Cited by 9 · see citing works

Lactonization of the Oncometabolite D-2-Hydroxyglutarate Produces a Novel Endogenous Metabolite

Berger, R. S., Wachsmuth, C. J., Waldhier, M. C., Renner, K., Thomas, S., Chaturvedi, A., Niller, H.-H., Bumes, E., Hau, P., Proescholdt, M. A., et al. (2021) · Cancers · doi:10.3390/cancers13081756 · Cited by 9 · see citing works

Effects of the STAMP-inhibitor asciminib on T cell activation and metabolic fitness compared to tyrosine kinase inhibition by imatinib, dasatinib, and nilotinib

Häselbarth, L., Karow, A., Mentz, K., Böttcher, M., Roche-Lancaster, O., Krumbholz, M., Jitschin, R., Mougiakakos, D., & Metzler, M. (2023) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03361-8 · Cited by 9 · see citing works

Divergent Processing of Cell Stress Signals as the Basis of Cancer Progression: Licensing NFκB on Chromatin

Vlahopoulos, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168621 · Cited by 8 · see citing works

Microenvironmental Metabolites in the Intestine: Messengers between Health and Disease

Zaurito, A. E., & Tschurtschenthaler, M. (2022) · Metabolites · doi:10.3390/metabo12010046 · Cited by 8 · see citing works

Synergistic lethality in chronic myeloid leukemia – targeting oxidative phosphorylation and unfolded protein response effectively complements tyrosine kinase inhibitor treatment

Häselbarth, L., Gamali, S., Saul, D., Krumbholz, M., Loschinski, R., Böttcher, M., Zou, D., Metzler, M., Karow, A., & Mougiakakos, D. (2023) · BMC Cancer · doi:10.1186/s12885-023-11623-6 · Cited by 7 · see citing works

Glycolysis and Autoimmune Diseases: A Growing Relationship

Rezaei, R., Tahmasebi, S., Atashzar, M. R., & Amani, D. (2020) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747820020154 · Cited by 7 · see citing works

Can the New and Old Drugs Exert an Immunomodulatory Effect in Acute Myeloid Leukemia?

Tarantini, F., Cumbo, C., Anelli, L., Zagaria, A., Specchia, G., Musto, P., & Albano, F. (2021) · Cancers · doi:10.3390/cancers13164121 · Cited by 7 · see citing works

idh-1 neomorphic mutation confers sensitivity to vitamin B12 in Caenorhabditis elegans

Ponomarova, O., Starbard, A. N., Belfi, A. C., Anderson, A. V., Sundaram, M. V., & Walhout, A. J. M. (2024) · Life Science Alliance · doi:10.26508/lsa.202402924 · Cited by 6 · see citing works

Regulation of CD4 + T cell differentiation and function by glucose metabolism

Liu, Y., Zhou, Y., Zhang, J., Li, J., & Zou, L. (2025) · Genes and Immunity · doi:10.1038/s41435-025-00340-8 · Cited by 6 · see citing works

Exploitable metabolic dependencies in MLL-ENL–induced leukemia

García-Cuéllar, M.-P., Lawlor, J., Böttcher, M., Mougiakakos, D., Metzler, M., & Slany, R. K. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001710 · Cited by 6 · see citing works

Cancer-specific metabolism: Promising approaches for colorectal cancer treatment

Jeong, K. (2019) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v11.i10.768 · Cited by 6 · see citing works

Machine Learning Identification of Immunotherapy Targets in Low-Grade Glioma Using RNA Sequencing Expression Data

Agarwal, P., Beale, O., Zhang, X., Sandlesh, P., Jaman, E., & Amankulor, N. (2022) · World Neurosurgery · doi:10.1016/j.wneu.2022.03.123 · Cited by 6 · see citing works

Metabolism and therapeutic response in acute myeloid leukemia with IDH1/2 mutations

Gabellier, L., Bosetta, E., Heiblig, M., & Sarry, J. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.01.011 · Cited by 6 · see citing works

Oxidation of α-hydroxy acids by D-2-hydroxyglutarate dehydrogenase enzymes

Quaye, J. A., Moni, B. M., Kugblenu, J. E., & Gadda, G. (2025) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2025.110355 · Cited by 4 · see citing works

Metabolic Reprogramming in Response to Freund’s Adjuvants: Insights from Serum Metabolomics

Mone, K., Garcia, E. J. T., Abdullatif, F., Rasquinha, M. T., Sur, M., Hanafy, M., Zinniel, D. K., Singh, S., Thomas, R., Barletta, R. G., et al. (2025) · Microorganisms · doi:10.3390/microorganisms13030492 · Cited by 4 · see citing works

Immunometabolic Regulation of Anti-Tumor T-Cell Responses by the Oncometabolite D-2-Hydroxyglutarate

Böttcher, M., & Mougiakakos, D. (2019) · Immunometabolism · doi:10.20900/immunometab20190007 · Cited by 4 · see citing works

Targeting CD4+ T Cell Glucose Metabolism: A Novel Immunotherapeutic Approach for Type 1 Diabetes

Niu, Y., Wang, N., Qiao, L., Huang, Z., Jing, G., Fu, S., & Tang, X. (2025) · Biomolecules · doi:10.3390/biom15060770 · Cited by 3 · see citing works

Immunometabolic Regulation of Anti-Tumor T-Cell Responses by the Oncometabolite D-2-Hydroxyglutarate

Böttcher, M., & Mougiakakos, D. (2019) · Immunometabolism · doi:10.20900/immunometab20190007 · Cited by 4 · see citing works

D-2-hydroxyglutarate supports a tolerogenic phenotype with lowered major histocompatibility class II expression in non-malignant dendritic cells and acute myeloid leukemia cells

Hammon, K., Renner, K., Althammer, M., Voll, F., Babl, N., Decking, S.-M., Siska, P. J., Matos, C., Cárdenas-Conejo, Z. E., Mendes, K., et al. (2024) · Haematologica · doi:10.3324/haematol.2023.283597 · Cited by 13 · see citing works

Oncometabolite d -2HG alters T cell metabolism to impair CD8 + T cell function

Notarangelo, G., Spinelli, J. B., Perez, E. M., Baker, G. J., Kurmi, K., Elia, I., Stopka, S. A., Baquer, G., Lin, J., Golby, A. J., et al. (2022) · Science · doi:10.1126/science.abj5104 · Cited by 292 · see citing works

IMMU-57. EFFECT OF THE ONCOMETABOLITE D2HG ON MYELOID-DERIVED SUPPRESSOR CELL POPULATIONS

Pumar, O. T., Figueroa, M. E., & Bayık, D. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad179.0589

Abstract 1025: Aberrant TCR activation and altered metabolism drive decreased T cell cytokine production in IDH mutated acute myeloid leukemia

Li, Z., Reinfeld, B. I., Reisman, B. J., Madden, M. Z., Potts, C. R., Rathmell, W. K., Rathmell, J. C., & Ferrell, P. B. (2020) · Cancer Research · doi:10.1158/1538-7445.am2020-1025